Clinical Trial Update: Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety trial evaluating an HIV-1 vaccine delivered intramuscularly and intranasally in healthy female participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV-1 vaccine

Snippet

Sponsor: Mymetics Corporation | Conditions: HIV-1 | Phase 1 | Status: COMPLETED